Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2762 |
|
Actual shortage: | 228 (8%) | |
Anticipated shortage: | 1 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2524 (91%) | |
Discontinuation Reports |
256 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 253 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
13 (6%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
NOVAMOXIN | 250MG | CAPSULE | Resolved | 2020-01-09 | 2020-01-24 | 102938 |
TEVA-CEPHALEXIN | 250MG | CAPSULE | Resolved | 2020-01-17 | 2020-04-02 | 103572 |
TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2020-01-17 | 2020-01-30 | 103578 |
TEVA-TEMOZOLOMIDE | 250MG | CAPSULE | Resolved | 2020-01-30 | 2020-06-18 | 104927 |
TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2020-03-06 | 2020-07-03 | 107949 |
TEVA-CLARITHROMYCIN | 250MG | TABLET | Resolved | 2020-03-06 | 2020-06-11 | 108021 |
TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2020-03-26 | 2020-09-10 | 109556 |
NOVAMOXIN | 250MG | TABLET (CHEWABLE) | Resolved | 2020-03-26 | 2020-07-09 | 109604 |
ACT LEVOFLOXACIN | 250MG | TABLET | Resolved | 2020-04-02 | 2020-07-23 | 110652 |
NOVAMOXIN | 250MG | CAPSULE | Resolved | 2020-04-02 | 2020-08-14 | 110667 |
TEVA-NAPROXEN | 250MG | TABLET | Resolved | 2020-04-03 | 2020-05-08 | 110749 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2020-04-10 | 2020-04-23 | 111841 |
ACT TERBINAFINE | 250MG | TABLET | Resolved | 2020-04-10 | 2023-10-03 | 111874 |
ACT CIPROFLOXACIN | 250MG | TABLET | Resolved | 2020-05-08 | 2020-05-21 | 114436 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2020-05-14 | 2020-06-04 | 115196 |
TEVA-AMPICILLIN | 250MG | CAPSULE | Resolved | 2020-05-14 | 2020-09-03 | 115210 |
TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2020-07-10 | 2021-01-14 | 119956 |
ACT TERBINAFINE | 250MG | TABLET | Resolved | 2020-07-23 | 2020-09-24 | 120905 |
TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2020-09-17 | 2020-11-12 | 124477 |
TEVA-TEMOZOLOMIDE | 250MG | CAPSULE | Resolved | 2020-09-25 | 2020-11-07 | 125028 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |